Summit Pharmaceuticals International

SPI, a wholly-owned subsidiary of Sumitomo Corporation, is a comprehensive service company specializing in drug development and commercialization. It has 90 professionals across five locations in Japan, including its own API warehouse and analytical laboratories. SPI has an excellent track record in activities such as being the exclusive agent for ATCC (the world's largest gene/cell research bank) in the United States, as well as in the supply of APIs, intermediates, and active pharmaceutical ingredients.